• Contact
Saturday, June 28, 2025
Register
Login
European Press
Advertisement
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video
No Result
View All Result
European Press
No Result
View All Result

FDA clears Sora Neuroscience’s brain mapping software

27 June 2025
in Health
Reading Time: 2 mins read
A A
FDA clears Sora Neuroscience’s brain mapping software
ShareShareShareShareShare


Sora Neuroscience, a brain AI software company, announced it received FDA clearance for its Cirrus brain mapping software, which is used for helping neurosurgeons make clinical decisions. 
Cirrus uses functional magnetic resonance imaging (fMRI) to generate maps of vital brain networks to help physicians plan for brain surgery.
According to PLOS One, fMRI is a “tool for pre-surgical evaluation of the eloquent cortex. Resting state (rs-fMRI) enables functional localization without patient participation and can evaluate numerous functional domains with a single imaging session.”
Sora said in a statement that it has a non-exclusive distribution connection with Prism Clinical Imaging to make Cirrus available to users of Prism’s brain mapping platform. 
Sora stated that Prism workflow allows clinicians to utilize fMRI, diffusion tensor imaging (DTI) and other imaging tools to diagnose and plan treatment for brain disorders, including tumors, epilepsy and other neurological conditions. 
Loyola Medicine describes DTI as an MRI technique that measures the rate of water diffusion between cells to understand and create a map of the body’s internal structures that is commonly used to provide imaging of the brain.
“Cirrus maps can help neurosurgeons in making clinical decisions that strike the correct balance between aggressive resection and functional preservation in surgical patients,” Dr. Eric Leuthardt, a neurosurgeon at Washington University School of Medicine and cofounder of Sora Neuroscience, said in a statement. 
THE LARGER TREND
Other companies in the software brain imaging space include Hyperfine, which in May announced that the FDA cleared its Optive AI software for its Swoop system, an AI-powered portable MRI system for the brain. The software upgrade marked the tenth-generation release of Optive AI. 
In an intensive care unit, the Swoop system enables brain imaging at the point of care while eliminating the need to transport critically ill patients to radiology. 
There is extensive data on the role of MRI in evaluating multiple sclerosis (MS), which is a chronic inflammatory and neurodegenerative disease where one’s immune system attacks the central nervous system. 
Symptoms may include fatigue, tremors, motor dysfunction, nystagmus, numbness, loss of coordination or balance, disturbances in speech and vision, and cognitive impairment.
According to a study published in the journal NeuroImage, the application of structural and functional MRI techniques in patients with MS has enhanced “the understanding of the mechanisms responsible for clinical disability and cognitive impairment in this condition.”
Brain mapping structural and functional brain networks could improve the understanding of the brain structure-function relationship and of the pathophysiological aspects of neurological and psychiatric disorders.
In a study published in Neuroscience, researchers created a four-dimensional brain map that shows how MS-like lesions form, giving new insights into the earliest stages of the disease. 
Using a marmoset model rather than mice, researchers “tracked lesion development in real-time with MRI imaging, identifying vulnerable brain regions weeks before visible damage occurred.”
A significant finding was the role of a “specific type of astrocyte expressing the gene SERPINE1, which clustered near brain borders and influenced immune responses and myelin repair. These discoveries could help detect MS earlier and guide future treatments to slow or stop disease progression.”

Credit: Source link

Related Posts:

  • FDA clears Sora Neuroscience’s brain mapping software
    FDA clears Sora Neuroscience's brain mapping software
  • FDA clears Hyperfine's Optive AI software for brain imaging
    FDA clears Hyperfine's Optive AI software for brain imaging
  • Chipiron raises $17M for miniature MRI prototype
    Chipiron raises $17M for miniature MRI prototype
  • Emerging technologies in healthcare, part 1: Precision Neuroscience
    Emerging technologies in healthcare, part 1:…
ShareTweetSendPinShare
Previous Post

Giants training camp will feature join Jets practices

Next Post

Best early Prime Day drone deals

Next Post
Best early Prime Day drone deals

Best early Prime Day drone deals

Recommended

TGA announces investigation into Choice claims on sunscreen

TGA announces investigation into Choice claims on sunscreen

18 June 2025
The payoff Yankees are hoping for from Dodgers series

The payoff Yankees are hoping for from Dodgers series

2 June 2025
Suspect in stabbing attack that killed three at German festival admits guilt at trial

Suspect in stabbing attack that killed three at German festival admits guilt at trial

10 June 2025
Mostly AI launches 0k global challenge to spotlight privacy-safe synthetic data for AI development

Mostly AI launches $100k global challenge to spotlight privacy-safe synthetic data for AI development

12 June 2025
Starmer thanks business for footing tax bill

Starmer thanks business for footing tax bill

27 June 2025
European Press

European-press.com shares the latest news from Europe and around the world. It covers topics such as business, technology, sports, health, entertainment, and lifestyle. Feel free to get in touch with us!

Disclaimer  Privacy Policy – EU  Imprint 

Contact Us

What’s New Here!

  • What’s stopping people from having as many kids as they want?
  • Celebrity Gogglebox viewers divided as they call out ‘insufferable’ stars
  • The odd new worlds we’ve discovered in 2025
  • My girlfriend doesn’t want me to spend money on my kids

Subscribe to Our Newsletter

Copyright 2025 © EUROPEAN PRESS All rights on our posts reserved!

Translate »
European Press
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video

Copyright 2025 © EUROPEAN PRESS All rights on our posts reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
×